Physician profile
Quanita J Crable
NPI 1376735530
$175,613.64
in general payments reported to CMS, 2019-2025
33 companies · $131K in 2025
The $131K reported for 2025 was more than what 99% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $227 · 2020: $8,489 · 2021: $4,672 · 2022: $788 · 2023: $3,647 · 2024: $27K · 2025: $131K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $100K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $31K · Travel and Lodging: $17K · Food and Beverage: $8,339 · Consulting Fee: $5,400 · Gift: $67.67.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $99,780.84 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $31,000.00 |
| Travel and Lodging | $16,849.45 |
| Food and Beverage | $8,338.80 |
| Consulting Fee | $5,400.00 |
| Gift | $67.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $166,824.78 | 2020-2025 | Da Vinci Surgical System, Da Vinci Sp |
| Mimedx Group, INC. | $5,591.52 | 2024-2025 | Bovine Collagen |
| Sumitomo Pharma America, INC. | $722.29 | 2023-2025 | Myfembree |
| Myovant Sciences INC. | $429.14 | 2021-2022 | |
| Abbvie INC. | $297.38 | 2019-2023 | Lo Loestrin Fe |
| Coopersurgical, INC. | $236.06 | 2019-2025 | Ally II Ups, Paragard T 380a |
| Pfizer INC. | $182.04 | 2021-2024 | |
| Exeltis, USA INC. | $160.52 | 2019-2025 | Slynd |
| Hologic Sales and Service, LLC | $129.35 | 2019-2025 | Myosure Tissue Removal Device, Novasure |
| Astellas Pharma US INC | $113.04 | 2024-2025 | Veozah |
| Millicent US INC | $109.39 | 2020-2025 | Intrarosa, Femring |
| Caldera Medical, INC | $81.70 | 2021 | |
| Mylan Pharmaceuticals INC. | $81.21 | 2020-2022 | |
| Avion Pharmaceuticals | $79.44 | 2020-2023 | Balcoltra |
| Organon LLC | $59.50 | 2022-2025 | Nexplanon |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Scynexis, INC. | $59.47 | 2021-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $55.72 | 2021-2022 | |
| Agile Therapeutics, INC. | $47.70 | 2021-2023 | Twirla |
| Mayne Pharma Commercial LLC | $45.47 | 2021-2022 | |
| Fisher Scientific Company L.L.C. | $39.49 | 2024 | Procalcitonin |
| Davol INC. | $33.54 | 2025 | Arista |
| Therapeuticsmd, INC. | $31.87 | 2020-2021 | |
| Aspira Women'S Health INC | $23.88 | 2022 | |
| Axonics, INC. | $23.58 | 2023 | Bulkamid |
| Evofem Biosciences, INC. | $23.51 | 2021 | |
| Meditrina | $21.47 | 2025 | |
| Mycovia Pharmaceuticals, INC. | $19.77 | 2022 | |
| Lupin INC. | $17.92 | 2020 | |
| Roche Diagnostics Corporation | $17.01 | 2021 | |
| Duchesnay USA Incorporated | $16.49 | 2019 | |
| Merck Sharp & Dohme LLC | $15.44 | 2019 | |
| Vertical Pharmaceuticals, LLC | $12.64 | 2019 | |
| Amag Pharmaceuticals, INC. | $11.31 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Quanita Crable listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.